癌胚抗原相关细胞粘附分子19抗体
规格：1mg/1ml
英文名： CEACAM19
别名： Carcinoembryonic antigen like 1; Carcinoembryonic antigen like 1 antibody Carcinoembryonic antigen related cell adhesion molecule 19; Carcinoembryonic antigen related cell adhesion molecule 19; CEA re
分子量： 29kDa
储存液：0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glyce
克隆类型：Polyclonal
亚型：IgG
纯化方法：affinity purified by Protein A
**原：KLH conjugated synthetic peptide derived from human CEACAM19
交叉反应：Human, Mouse, Rat, Cow, Horse, Sheep,
细胞定位：细胞膜
癌胚抗原相关细胞粘附分子19抗体产品介绍：background: CEACAM19 belongs to the carcinoembryonic antigen (CEA) gene family. It encodes a putative glycoprotein which is membrane-bound via a transmembrane domain. Like all members of the CEACAM family, the CEACAM19 protein is a single-pass type I membrane protein and consists of a single extracellular N domain. CEACAM19 expression is ubiquitous with highest expression in prostate, uterus, fetal brain, mammary gland, adrenal gland, skeletal muscle, small intestine, and kidney癌胚抗原相关细胞粘附分子19抗体. Subcellular Location: Membrane; Single-pass type I membrane protein (Potential). Tissue Specificity: Ubiquitous with highest expression in prostate, uterus, fetal brain, mammary gland, adrenal gland, skeletal muscle, small intestine, and kidney, and lower expression in lung, cerebellum, testis, liver, pancreas, bone marrow and ovary. Similarity: Belongs to the immunoglobulin superfamily.癌胚抗原相关细胞粘附分子19抗体 CEA family. Database links: UniProtKB/Swiss-Prot: Q7Z692.2 Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
癌胚抗原相关细胞粘附分子19抗体产品应用：WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.
研究领域：肿瘤 细胞生物 **学 细胞粘附分子
储存条件： Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
来源： Rabbit
外观： Lyophilized or Liquid
- 温馨提示：为规避购买风险，建议您在购买前务必确认供应商资质与产品质量。
- 免责申明：以上内容为注册会员自行发布，若信息的真实性、合法性存在争议，平台将会监督协助处理，欢迎举报